Revolutionizing the Treatment of Hemophilia
Inspiration Biopharmaceuticals is focused on developing innovative recombinant blood coagulation factor products to fundamentally change the treatment of hemophilia.
BioWorld Coverage| Date | Newsletter Title | |
|---|---|---|
| Jan 10, 2008 | BioWorld Coverage | View Newsletter |
| Nov 13, 2007 | Filing of IND for Novel Recombinant Factor IX Product, IB1001 | View Newsletter |
| Jul 11, 2007 | N-Glycan Sialylation is Important for In Vivo Recovery of Recombinant Factor IX | View Newsletter |
| Jul 4, 2007 | Inspiration Biopharmaceuticals Presents At ISTH Annual Meeting | View Newsletter |
| Mar 1, 2007 | Inspiration Biopharmaceuticals Announcement | View Newsletter |